Ray Co

Ray Co Operating Cash Flow

The Operating Cash Flow of Ray Co (228670.KQ) as of Oct 29, 2026 is 12.85 B KRW. In the previous year, Operating Cash Flow was 204.51 M KRW — a change of 6,183.15% (higher).

Operating Cash Flow

12.85 BKRW

YoY

6,183.15%

Last updated:

Operating Cash Flow of Ray Co is 2025 12.85 B KRW. Operating Cash Flow of Ray Co was 2024 204.51 M KRW. It decreases by 6,183.15% higher compared to the previous year.

The Ray Co Operating Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Cash Flow
Date
Operating Cash Flow
Jan 1, 2018
4.30 B KRW
Jan 1, 2019
6.04 B KRW
Jan 1, 2020
2.90 B KRW
Jan 1, 2021
11.17 B KRW
Jan 1, 2022
-8.23 B KRW
Jan 1, 2023
-22.79 B KRW
Jan 1, 2024
204.51 M KRW
Jan 1, 2025
12.85 B KRW
The Ray Co Operating Cash Flow history
YEAROperating Cash FlowYoY
12.85 BKRW+6,183.15%
204.51 MKRW-100.90%
-22.79 BKRW+176.88%
-8.23 BKRW-173.67%
11.17 BKRW+284.81%
2.90 BKRW-51.93%
6.04 BKRW+40.53%
4.30 BKRW+290.23%
1.10 BKRW+89.23%
582.04 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Ray Co Stock analysis

What does Ray Co do? Ray Co., Ltd. generates revenue through the manufacturing and sale of advanced technology medical devices, focusing on digital diagnostic systems and digital therapy solutions. The company produces dental radiography equipment such as x-ray systems and cone beam computed tomography (CBCT) systems, alongside 3D scanning, dental computer aided design (CAD), and 3D printers for prosthodontics, orthodontics, and implant surgery. Domestic and overseas markets purchase these products, with the company operating through subsidiaries to distribute its offerings globally. Digital diagnostic systems like dental radiography equipment and CBCT systems are sold to healthcare providers and dental clinics, while digital therapy solutions including 3D scanning and CAD systems target dental laboratories and surgical centers. The firm's product portfolio serves both domestic and international clients, leveraging its subsidiaries for global distribution channels. Ray Co., Ltd. emphasizes advanced technology in its medical device offerings, with digital therapy solutions such as 3D printers and CAD systems being key revenue drivers. The company's focus on dental-specific applications ensures targeted sales to specialized healthcare segments, including prosthodontics, orthodontics, and implant surgery practices. Ray Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ray Co stock

Operating Cash Flow of Ray Co is 12.85 B KRW in 2025.

Operating Cash Flow of Ray Co changed from 204.51 M KRW to 12.85 B KRW, representing a 6,183.15% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Ray Co since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's Ray Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Ray Co

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Ray Co